WO2002022253A2 - Adsorbens mit unterschiedlich modifizierten oberflächenbereichen, verfahren zu dessen herstellung und verwendung davon - Google Patents
Adsorbens mit unterschiedlich modifizierten oberflächenbereichen, verfahren zu dessen herstellung und verwendung davon Download PDFInfo
- Publication number
- WO2002022253A2 WO2002022253A2 PCT/EP2001/010678 EP0110678W WO0222253A2 WO 2002022253 A2 WO2002022253 A2 WO 2002022253A2 EP 0110678 W EP0110678 W EP 0110678W WO 0222253 A2 WO0222253 A2 WO 0222253A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- carrier material
- adsorbent
- binding sites
- pores
- monomer
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3285—Coating or impregnation layers comprising different type of functional groups or interactions, e.g. different ligands in various parts of the sorbent, mixed mode, dual zone, bimodal, multimodal, ionic or hydrophobic, cationic or anionic, hydrophilic or hydrophobic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3206—Organic carriers, supports or substrates
- B01J20/3208—Polymeric carriers, supports or substrates
- B01J20/321—Polymeric carriers, supports or substrates consisting of a polymer obtained by reactions involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3206—Organic carriers, supports or substrates
- B01J20/3208—Polymeric carriers, supports or substrates
- B01J20/3212—Polymeric carriers, supports or substrates consisting of a polymer obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3214—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the method for obtaining this coating or impregnating
- B01J20/3217—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond
- B01J20/3219—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond involving a particular spacer or linking group, e.g. for attaching an active group
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/327—Polymers obtained by reactions involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/3272—Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/328—Polymers on the carrier being further modified
- B01J20/3282—Crosslinked polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
Definitions
- Adsorbent with differently modified surface areas process for its production and use thereof
- the present invention relates to an adsorbent for whole blood in the form of essentially spherical, non-aggregated particles, which comprises a porous carrier material with an average pore size of ⁇ 1.5 microns, wherein a maximum of 50% of the pore volume can be present in pores which have a pore size of > 1.5 ⁇ m, the outer surfaces of the porous carrier material having at least one surface modification Mi, as a result of which the outer surface essentially does not interact with blood cells, and the inner surfaces of the porous carrier material, ie the surfaces of the pores of the porous carrier material, at least one Have surface modification M 2 , which interacts with substances contained in blood. Furthermore, the present invention relates to a method for producing such an adsorbent, the use of this adsorbent, and an adsorber which comprises the adsorbent according to the invention in a housing.
- Adsorbents are widely used in medical technology. Adsorbers with adsorbents which remove low-density lipoproteins (LDL) from blood or blood components or reduce their concentration are frequently described, as is known from DE 39 32 971. This publication describes the adsorbent material as an organic carrier with a fixed particle size and exclusion limit, which has a functionalization on its surface to which the LDL molecule binds.
- LDL low-density lipoproteins
- LDL adsorbers made of porous polymethacrylate particles which are coated with polyacrylic acid (PAS), PAS being bound both on the outer surface which bounds the particles and on the inner surface which surrounds the pores. Since the blood cells show only slight interactions with PAS, such an adsorbent is suitable for whole blood, ie the adsorbent particles let the blood cells pass without interacting with them, ie without activating, binding or damaging them. Thus, according to this method, the whole blood can be passed without prior separation of the blood cells the adsorber are directed.
- the LDL is separated here by means of a size exclusion mechanism and not via a specific binding of the LDL to a functional group adhering to the support.
- the whole blood tolerance of an adsorbent is very unusual since the carrier material normally leads to complement activation and / or triggers platelet aggregation and adhesion.
- the blood cells must first be separated from the blood plasma, whereupon only the plasma is passed over the adsorber. After the immune complexes have been separated by binding to the protein C1q, the blood cells must be reunited with the purified blood plasma. This procedure is complex and burdensome and risky for the patient.
- the whole blood adsorbents described in the literature consist of particles which are so large that they Form spaces in which the blood cells can move.
- the particles also have pores which lead to an inner surface. These pores are of sufficient size that even macromolecules can penetrate them. However, the pores are so small that the penetration of blood cells is excluded.
- the blood cell len only have contact with the outer surface of the particles.
- these particles must be as spherical and unaggregated as possible in order to have a “smooth” and also an inert outside, so that the platelets slide thereon.
- porous materials whose surfaces are chemically functionalized so that the outer surface of the porous materials is electro-neutral and hydrophilic, while the inner surface can be designed with so-called functional ligands.
- Whole blood compatible materials are not described.
- These porous materials are produced by first introducing epoxy groups into a porous base support, both the pore surfaces and the outer surfaces of the base support being functionalized with epoxy groups and then the epoxy groups being opened catalytically by reaction with a nucleophile.
- a particulate catalyst with a particle size larger than the average pore diameter of the porous base support is used, so that a reaction in the pores cannot take place.
- the remaining epoxy groups on the pore surfaces are implemented by introducing functional ligands.
- a particulate catalyst has considerable disadvantages since it is difficult to separate the particulate catalyst from the coated support material.
- a reaction may and may only take place at contact points between the catalyst particles and the carrier material particles, as a result of which very long reaction times and extensive stirring are required in order to achieve an almost complete conversion of the surface.
- the long stirring can also lead to abrasion of the catalyst particles, which can contaminate the adsorber with catalyst residues.
- magnetic catalyst particles it cannot be excluded that catalyst particles remain in the adsorbent.
- these catalyst particles can lead to problems, in particular when purifying whole blood through interactions with blood components, so that such a catalyst is not suitable for whole blood.
- the object of the present invention was therefore to provide an adsorbent which is compatible with whole blood and which cannot be reached by blood cells Places groups that can interact with substances to be separated from the blood. Furthermore, a method is to be provided with which such an adsorbent can be produced simply and economically.
- an adsorbent for whole blood is provided in the form of essentially spherical, non-aggregated particles, which comprises a porous carrier material with an average pore size of ⁇ 1.5 ⁇ m, it being possible for a maximum of 50% of the pore volume to be present in pores which have a pore size of> 1.5 ⁇ m, the outer surfaces of the porous carrier material having at least one surface modification Mi, as a result of which the outer surface essentially does not interact with blood cells, and the inner surfaces of the porous carrier material, ie the surfaces of the pores of the porous carrier material , have at least one surface modification M 2 which interacts with substances contained in blood.
- FIG. 1 schematically shows a cross section through an embodiment of an adsorbent particle 1 according to the invention, which has a carrier material 2 with pores 3 and modifiable binding sites 4, as well as associated surface modifications Mi and M 2 .
- the pores 3 of the carrier material 2 are enclosed by “inner” surfaces 6, which have surface modifications M 2 bound.
- the binding sites on the “outer” surface 5, ie the surface surrounding the adsorber particle 1, are also of the surface modifications M 2 on the inner Surfaces 6 different surface modifications Wed occupied.
- Figures 2 and 3 show an example of two pore size distributions, which were measured according to the method described below analogously to DIN 66 133 on an adsorbent according to the invention.
- the “outer surfaces” of a particle are understood to mean the surface surrounding the particle.
- the “inner surfaces” of a particle are understood to mean the surfaces which surround the pores of the particle, i.e. the surfaces of the pores of the particle.
- the term “interaction” encompasses activation, attachment, conversion and / or damage to substances and / or cells contained in whole blood. According to the invention, a selective interaction is preferred. The interaction can also be specific according to another embodiment.
- the adsorbent according to the invention is particulate.
- the particles of the adsorbent according to the invention are essentially spherical and not aggregated. Spherical particles, in contrast to irregularly shaped particles or irregularly shaped aggregates of particles, have the advantage that they do not undesirably retain blood particles such as platelets.
- the porous carrier material of the adsorbent according to the invention has an average pore size or an average pore diameter with a value of ⁇ 1.5 ⁇ m, preferably ⁇ 1.0 ⁇ m, with a maximum of 50% of the pore volume in pores with a pore size of> 1.5 ⁇ m are present.
- the maximum average pore size of 1.5 ⁇ m is determined by the size of the smallest blood cells, which have a diameter of approximately 2 ⁇ m. With a maximum mean pore size as defined according to the present invention, it is ensured that essentially no blood cells can penetrate into the pores. If only very small or dissolved particles are to be separated from the blood, it is preferred to choose a porous carrier material with a smaller average pore size, for example 1 ⁇ m, 0.5 ⁇ m or 0.3 ⁇ m.
- the average pore size can be determined by mercury intrusion (mercury porosimetry) in accordance with DIN 66 133.
- the procedure is based on the measurement of the volume of mercury injected into a porous solid as a function of the pressure applied.
- a non-wetting liquid such as mercury only penetrates a porous system under pressure.
- the pressure to be applied is inversely proportional to the clear width of the pore openings.
- pores are detected, into which mercury can penetrate at the pressure used.
- the relationship between pore radius r p and pressure p is given by the Washburn equation:
- FIG. 2 shows a carrier material with a relatively small average pore size of approximately 200 nm.
- FIG. 3 shows a carrier material with a larger average pore size of approximately 1 ⁇ m.
- the adsorbent particles preferably have a grain size of 50 to 500 ⁇ m, more preferably 100 to 300 ⁇ m.
- the particles of the adsorbent should have a grain size of at least 50 ⁇ m, since the largest blood cells or blood cells present in the whole blood have a diameter of 20 ⁇ m.
- the sieve which holds back the adsorbent must therefore have a mesh size of at least 25 ⁇ m, preferably at least 40 ⁇ m, so that all blood cells are let through.
- the space between the particles is sufficient for the passage of blood cells.
- the adsorbent according to the invention comprises a porous carrier material. It can be assumed that a porous particulate carrier material has already been produced, its outer and inner surfaces being modified according to the invention.
- carrier materials are suitable, for example glasses, carbohydrates, Sepharose, silica or organic carrier materials, such as copolymers of acrylates or methacrylates and polyamides.
- the carrier material in this embodiment preferably consists of organic material, and copolymers derived from (meth) acrylic acid esters and / or amides are particularly preferred. These preferably have epoxy groups.
- (meth) acrylic includes both the corresponding acrylics - To understand as well as methacrylic compounds.
- the porous carrier material to be used according to the invention has modifiable binding sites on its outer and inner surfaces which can be converted into surface modifications Mi and / or M 2 .
- Particularly preferred as the binding site is a strained heterocyclic system as a functional group which can bind further functional groups to a support material by ring covalent, in particular nucleophilic ring opening, by direct covalent binding and thus carries the material as a surface modification Mi and / or M 2 of such functional groups.
- the carrier material particularly preferably contains oxirane groups or epoxy groups as binding sites for such functional groups.
- a crosslinked statistical copolymer which is obtained by polymerizing ethylene glycol di (meth) acrylate and glycidyl (meth) acrylate and / or allyglycidyl ether is preferred as the carrier material.
- a particulate, porous carrier material such as glasses, carbohydrates, Sepharose, silica or organic carrier materials, one is by polymerization of the monomeric units
- the network structure is preferably produced by suspension polymerization.
- Such a copolymer is commercially available under the name Eupergit C250L or Eupergit FE162 from Röhm GmbH.
- a “surface modification” is understood according to the invention to mean a preferably organic end group, substance, compound and / or precursor compound which is suitable for binding to binding sites of a carrier material and which, when bound to a carrier material, preferably has the ability to exhibits selective interaction with certain substances or groups of substances contained in a solution.
- the outer surface of the particles of the carrier material has a surface modification Mi which shows essentially no interaction with blood cells, i.e. the outer surface of the particles is, so to speak, "smooth" or inert to blood cells.
- the surface modification Mi is preferably the reaction product of the implementation of the binding sites on the surfaces at least one poly (carboxylic acid), albumin, heparin, heparan sulfate, polyethylene oxide and block copolymers made of PE and polypropylene oxide (PPO) and / or a polymyxin.
- Polyacrylic acid and heparin are particularly preferred.
- poly (meth) acrylic acid or corresponding terms as used below stand for those compounds which can be derived from acrylic acid or from methacrylic acid or a mixture thereof.
- Poly (meth) acrylic acids are polymers of the formula - (CH 2 -C (H) (COOH)) n - and / or - (CH 2 -C (CH 3 ) obtained by radical polymerization of acrylic acid and / or methacrylic acid ) (COOH)) n - understood.
- the poly (meth) acrylic acids are also accessible by hydrolysis of polymeric (meth) acrylic acid derivatives, such as esters, amides, nitriles.
- a poly (meth) acrylic acid which is particularly suitable according to the invention has, for example, a weight average molecular weight of 10 2 g / mol to 10 7 g / mol.
- Polymyxins are peptide antibiotics that are only effective against Gram-negative bacteria.
- Polymyxin B is cyclopeptides with L-2,4-diaminobutyric acid residues and a D-amino acid.
- the surface modification Mi can have an interaction with substances other than blood cells. This is possible as long as the surface modification M- t continues to have no interactions with blood cells, but only interacts selectively with other substances contained in the blood. According to this embodiment, the surface modification Mi can also be a functional surface modification.
- the surface modification M 2 interacts with substances contained in the blood, whereby only those substances can come into contact with the surface modification M 2 that are small enough, depending on the selected pore size, to penetrate into the pores.
- the surface modification M 2 is thus a so-called functional surface modification, whereby functional surface modifications are understood to mean, for example, separation effectors or also catalysts or enzymes. Separation effectors create selective interactions that can be used for chromatographic separations or other distribution methods such as liquid-liquid distribution. Because the blood cells can not penetrate into the pores and thus can not come into direct contact with the surface modification M 2, it is possible to provide the inner surface of the adsorbent particles incompatible blood cell with a Surface modification m 2.
- the at least one surface modification M 2 preferably comprises at least one immune adsorber present on the inner surface.
- an “immunoadsorber” is understood to mean a compound which is capable of entering into a preferably specific bond with certain substances or groups of substances by means of an immune reaction.
- Particularly preferred immunoadsorbents are those which consist of the group consisting of the complement factor C1q, amine-containing functional groups, peptides, antibodies, such as monoclonal or polyclonal anti-fibrinogen or anti-fibrin antibodies, and antigens, such as synthetic A / B -Blood group antigens as well as DNA and RNA or their mirror molecules are selected.
- the surface modification Mi and / or M 2 is functional groups, these can be covalently connected to the carrier material via a spacer.
- a “spacer” is understood to mean organic bridge members with different chemical structure and length, with the aid of which organic functional groups can be bound to the surface of a carrier material. However, such functional groups are preferably applied directly as surface modifications Mi and / or M 2 without a spacer A reaction step can be avoided by the direct connection of a functional group to the support material.
- substances contained in whole blood can be separated which have approximately the same or preferably a smaller diameter than the selected mean pore size of the porous carrier material.
- the average pore size is preferably chosen so that the pores are substantially larger than the particles to be separated.
- sterilization such as gamma radiation, plasma treatment or ethylene oxide treatment (in particular heat sterilization, for example at 121 ° C.), since the treated blood is to be returned to the patient and no sepsis or May cause inflammation. Heat sterilizability at 121 ° C. and 1 bar gauge pressure is preferred, optionally in conjunction with a stabilizing pretreatment.
- the adsorbent according to the invention enables substances contained in blood to be separated from whole blood, even if the surface modification M 2 required for the separation would show a harmful interaction with blood cells, since the blood cells cannot penetrate into the pores of the adsorbent, on the inner walls of which the surface modification M 2 is localized only.
- This eliminates extracorporeal steps, such as the separation of blood cells, the treatment of the isolated plasma and the bringing together of the blood components, which increases the biocompatibility of the method and, for example, further significantly reduces the risk of complement activation.
- the elimination of extracorporeal steps shortens the treatment time and simplifies the procedure, thereby increasing the safety and well-being of the patient.
- the present invention further relates to a method for producing an adsorbent, which comprises the steps: providing a particulate, porous carrier material which has binding sites which can be modified on the outer and inner surfaces,
- the binding sites on the inner surfaces of the carrier material are modified from the pores to form at least one surface modification M 2 with a reaction solution which is not capable of modifying the surface modifications Mi.
- the pores of the carrier material are first filled with a medium which is liquid under the conditions of the filling. Under the conditions of the modification, this medium is essentially not miscible with a solution capable of essentially completely modifying binding sites on the surfaces of the carrier material to at least one surface modification Mi.
- liquid medium under the conditions of filling encompasses media which can be introduced or filled into the pores of a carrier material and which can be substantially completely removed from these pores again and which, under the conditions of the modification, essentially do not contain one a solution capable of substantially completely modifying binding sites on the surfaces of the carrier material to form at least one surface modification Mi.
- Such media can consist of a single medium, of mixtures of at least two of these and / or solutions.
- the medium will usually be one that is liquid at room temperature. According to a particular embodiment, however, the medium can also be gaseous at room temperature.
- the pores are then filled, for example at a low temperature and / or increased pressure, and the binding sites on the outer surfaces are also modified under these conditions.
- This embodiment has the advantage that a gaseous medium at room temperature can be removed from the pores particularly easily.
- the medium can be solid at room temperature.
- the pores of the carrier material can then be filled, for example with heating.
- This embodiment has the advantage that the pores are filled with the medium particularly permanently, for example for longer reactions.
- this filling of the pores with a medium can be carried out by immersing and swelling the particles of the porous carrier material in a medium which is liquid at room temperature in the simplest case, so that the air is essentially completely displaced from the pores of the carrier material , Furthermore, the particles can also be placed in an airtight container, whereupon the air is removed from the container and thus also from the pores of the porous carrier material by applying a vacuum, and then the medium into the evacuated container under conditions in which this medium is liquid is to which particles are placed.
- the excess liquid medium can be briefly suctioned off from the carrier material particles, for example using a suction filter, without the medium contained in the pores being removed again.
- the reaction solution for modifying the binding sites on the surfaces of the support material is then added to the particles for a surface modification Mi.
- the medium for filling the pores is essentially immiscible with this reaction solution under the conditions of the modification.
- a modification Mi of the outer surfaces or at Use of an aqueous-based reaction solution preferably a hydrophobic medium used as the pore-filling or pore-forming medium.
- hydrophobic medium particularly preferred as the hydrophobic medium are those media which are selected from the group consisting of linear or branched, acyclic or cyclic ci- to C 2 o-alkanes, such as pentane, hexane, heptane, octane, nonane, decane, cyclohexane, and linear or branched, acyclic or cyclic C 5 - to C 2 o-alkanols, such as hexanol, octanol, decanol, undecanol and dodecanol, linear and branched, acyclic or cyclic C 2 - to C3o-carboxylic acid esters and aromatic C 6 - to C2o Hydrocarbons and mixtures thereof are selected.
- the binding sites on the outer ones Surfaces of the carrier material are essentially completely modified by converting them to at least one surface modification Mi.
- the term “essentially complete modification” means that essentially all of the binding sites present on a surface of the carrier material, either the outer surface or the inner surface, are converted to surface modifications Mi or M 2 and thus essentially no free or modifiable binding sites
- the respective reaction solutions preferably each contain an excess of modifying agent.
- the term “modifying” includes changing, converting, creating and / or destroying binding sites on the respective surface of the porous carrier material.
- the term “modifying” means converting binding sites on the surfaces of the porous carrier material with, for example, nucleophiles or electrophiles for surface modifications Mi and / or M 2 .
- endurenmodifi- ornaments Mi preferably have the property according to the invention that they do not interact with blood, whereas surface modifications M 2 interact with substances present in the solution, suspension or dispersion to be separated, such as blood.
- the reaction solution required for the modification and subsequently optionally also the medium which is used to modify the binding sites on the outer surfaces of the carrier material to form at least one surface modification Mi enabled solution is essentially immiscible, removed from the pores, for example by suction, heating, possibly longer vacuum and / or washing out with an easily removable, further medium.
- the binding sites on the inner surfaces of the porous carrier material are modified. If the reaction solution for the surface modification M 2 is miscible with the medium present in the pores, the medium can remain in the pores and does not necessarily have to be removed, since mixing the medium in the pores with the reaction solution to modify the binding sites for surface modifications M 2 and diffusion of this reaction solution into the pores, the binding sites in the pores can also be modified. In most cases, however, it will be preferred to first remove the medium from the pores.
- the inner surfaces of the carrier material are also preferably substantially completely modified to at least one surface modification M 2 .
- the surface modifications M 2 can also be present before the modification of the binding sites on the outer surfaces to surface modifications Mi on the surfaces of the porous carrier material. According to this embodiment, if necessary, all the binding sites on the inner and outer surfaces can be closed first Surface modifications M 2 are implemented. However, it may also be the case that the binding sites of the carrier material have the required binding properties of M 2 even without modification.
- Such a, optionally modified, carrier group M 2 is provided as carrier material in the method according to the invention in the step of providing a particulate, porous carrier material which has modifiable binding sites on the outer and inner surfaces.
- the steps of filling the pores of the carrier material with at least one medium which is liquid under the conditions of the filling and which is essentially immiscible under the conditions of modification with a solution, with which binding sites on the surfaces of the carrier material are essentially complete can be modified; the essentially complete modification of the binding sites on the outer surfaces of the carrier material to at least one surface modification Mi and the optional removal of the medium, which, under the conditions of the modification with a solution, with which binding sites on the outer surfaces of the carrier material can be essentially completely modified , is essentially immiscible, carried out from the pores according to an embodiment of the method according to the invention, wherein in the step of essentially completely modifying the binding sites on the outer surfaces of the carrier material to at least one surface modification Mi, the modification of the modifiable binding sites on the outer surfaces of the Carrier material can also be carried out, for example, by destroying the surface modifications M 2 .
- the adsorbent according to the invention by, after providing a particulate porous carrier material which has modifiable binding sites on the outer surfaces and the inner surfaces, essentially completely converting the binding sites on the outer surfaces of the carrier material into surface modifications Mi. are, this reaction being brought about by radiation which does not essentially penetrate the carrier material. Since such radiation cannot penetrate into the pores, there is no conversion of the binding sites on the carrier material into surfaces in the pores. Chen modifications Wed instead. Subsequently, binding sites on the inner surfaces of the carrier material can be converted to surface modifications M 2 , this conversion being effected without the above radiation.
- a method according to this embodiment comprises the following steps:
- a particulate, porous carrier material which has binding sites which can be modified on the outer surfaces and the inner surfaces and which can be converted to surface modifications Mi and / or M 2 , essentially completely modifying the binding sites on the outer surfaces of the carrier material to at least one surface modification Mi by means of a reaction which is brought about by radiation which does not essentially penetrate the carrier material and, if appropriate, substantially complete modification of the binding sites on the inner surfaces of the carrier material to at least one surface modification M 2 by means of a reaction which is not capable of modifying the surface modification Mi.
- the radiation which does not essentially penetrate the carrier material is preferably electromagnetic radiation in the UV or visible range.
- the porous support material provided already has a modifiable surface modification M 2 on all surfaces and that after the binding sites on the outer surfaces have been substantially completely modified, it is no longer necessary to modify the bonding sites on the inner surfaces.
- the porous carrier material described above which can be modified to form an adsorbent according to the invention, as mentioned at the beginning, starting from certain polymerizable compounds, by means of the following written suspension polymerization process are prepared.
- This method for producing an adsorbent comprises the following steps: producing a particulate, porous carrier material which has binding sites which can be modified on the outer and inner surfaces by suspension polymerization, a hydrophobic phase comprising at least one monomer, at least one crosslinking agent, a pore-forming medium and a polymerization initiator is dispersed in a continuous phase comprising water and at least one protective colloid, and the monomers and crosslinking agents located in the hydrophobic phase are polymerized, the pores of the resulting particulate porous carrier material being filled with the pore-forming medium, substantially completely Modifying the modifiable binding sites on the outer surfaces of the carrier material particles to at least one surface modification Mi and optionally removing the pore-forming medium from the pores s.
- the porous carrier material which can be modified to an adsorbent according to the invention, can also be produced by the suspension polymerization process described below, with a water-soluble monomer being added to the aqueous continuous phase, as a result of which the production of the porous Particles of the carrier material and the modification of the outer surfaces of these particles are carried out in one step.
- This further preferred method for producing an adsorbent comprises the following steps:
- a hydrophobic phase comprising at least one monomer, at least one crosslinking agent, a pore-forming medium and a polymerization initiator, in a continuous phase comprising water, at least one protective colloid and at least one water-soluble monomer which is essentially insoluble in the hydrophobic phase, the monomers and crosslinking agents located in the hydrophobic phase being polymerized to form a porous core and the at least one water-soluble monomer in the phase interface between hydrophobic and the continuous phase polymerizes to at least one surface modification Mi, at least some of the polymer chains formed from the water-soluble monomer being covalently bound to the forming porous core, and - if appropriate, removing the pore-forming medium from the pores.
- protective colloids or stabilizers customary in the art can be used in the aqueous continuous phase.
- One or more protective colloids from the group consisting of polyvinyl alcohol (PVA), polyvinyl pyrrolidone (PVP) and polyethylene glycol are preferably used.
- the monomer contained in the hydrophobic phase is preferably a monomer containing epoxide groups or a mixture of a monomer containing epoxide groups and at least one further monomer.
- the monomer containing epoxy groups is preferably a (meth) acrylic acid monomer containing epoxy groups.
- an epoxy group-containing (meth) acrylic acid monomer is understood to mean, in particular, one in which the residue which bears the epoxy group is bonded via the ester functionality of a substituted or unsubstituted (meth) acrylic acid.
- the residue which bears the epoxy group is bound in another way to the (meth) acrylic acid monomer, for example to one of the carbon atoms of the CC double bond.
- the (meth) acrylic acid monomer containing epoxy groups is glycidyl (meth) acrylate.
- a monomer with at least two polymerizable groups is used as the crosslinking agent, which leads to crosslinking of the growing polymer chains.
- crosslinking agent is understood to mean customary monomers used in the art with at least two polymerizable groups, the polymerizable groups being, for example, vinyl, acrylate or methacrylate groups.
- a monomer based on (preferably) is preferably used as a monomer with at least two polymerizable groups
- the monomer having at least two polymerizable groups is ethylene glycol di (meth) acrylate, and the two (meth) acrylate groups of such a monomer can also be replaced by another one, for example ⁇ , ⁇ -diols or generally alcohols with at least two OH groups derived linking group .
- the proportion of the crosslinking agent, based on the content of monomer in the hydrophobic phase can from 5 to 95 wt .-%, preferably 20 to 60 wt .-%, particularly preferably 40% by weight.
- the pore-forming medium is a mixture of at least two components, selected from linear, branched or cyclic alcohols with 5 to 14 carbon atoms and esters of mono- or dicarboxylic acids with 2 to 10 carbon atoms, which are mono- or polyvalent Alcohols with 1 to 6 carbon atoms are esterified.
- a component of the pore-forming medium described above can be a linear, branched or cyclic (primary, secondary or tertiary) alcohol having 5 to 14 carbon atoms, for example hexanol, octanol, decanol or dodecanol.
- Another component of the pore-forming medium described above can be an ester of a mono- or dicarboxylic acid with 2 to 10 carbon atoms, which is esterified with mono- or polyhydric alcohols with 1 to 6 carbon atoms, for example butyl acetate, diethyl succinate or glycerin tributate.
- a mixture of two components is used as the pore-forming medium or as the pore-forming agent, the resulting polymer being not soluble in any of the components, but one component which dissolves the oligomer which forms during suspension polymerization and the other component is incapable of to dissolve the oligomer that forms. Due to the specific selection of the components of the pore-forming medium, pore formation is made possible.
- oligomer means a material with a molecular weight of up to about 10 4 g / mol which forms in a suspension polymerization described above.
- the proportion of the pore-forming medium described above, based on the hydrophobic phase, can be from 20 to 90% by weight, preferably from 40 to 80% by weight, particularly preferably 70% by weight.
- a polymerization initiator to be used in the suspension polymerization processes described above is generally not particularly limited.
- a polymerization initiator from the group of azo compounds, peroxides and redox initiators can be used.
- a suitable azo compound or a suitable peroxide is used as the polymerization initiator.
- the polymerization initiator azobisisobutyronitrile or dibenzoyl peroxide is particularly preferred.
- the proportion of the polymerization initiator, based on the amount of monomer can be from 0.1 to 5% by weight, preferably 0.5 to 2% by weight, particularly preferably 1% by weight.
- the water-soluble monomer may be a monofunctional vinyl compound.
- the water-soluble monomer preferably has one or more polar groups.
- Preferred hydroxyalkyl methacrylates and / or aminoalkyl methacrylates are those which have an alkyl group of 1 to 10 carbon atoms, for example a methyl, ethyl, propyl or butyl group. Even more preferred is the water soluble monomer acrylic acid, N-vinyl-2-pyrrolidone or a combination thereof.
- the proportion of the water-soluble monomer can be 2% by weight to 80% by weight, based on the total starting monomer weight of the porous support material.
- the proportion of the water-soluble monomer is preferably 5% by weight to 50% by weight, based on the total starting monomer weight of the porous support material, particularly preferably 20 to 30% by weight.
- the present invention further relates to the use of the adsorbent according to the invention for separating biomolecules and / or pathogenic substances, such as toxins, from whole blood.
- biomacromolecules such as e.g. LDL and endotoxins, immunoglobulins, fibrin, fibrinogens, immune complexes, exotoxins, fibronectins and / or superantigens are removed.
- the present invention provides the use of the adsorbent according to the invention for producing an adsorber, comprising a housing and an adsorbent located therein, for separating biomolecules and / or pathogenic substances from whole blood.
- An adsorber equipped with the adsorbent produced according to the invention has a housing which is preferably in the form of a tube or column and which contains the adsorbent as filler material.
- the adsorber preferably has a volume of 250 to 1250 ml.
- the adsorber can be used individually or in double or multiple operation.
- the adsorber containing the adsorbent is preferably designed in such a way that it has a housing with an inlet region on the top through which the blood passes to the adsorber is supplied, in which case the outlet is at the bottom of the housing of the adsorber.
- Substances that originate from the adsorbent material and are returned to the patient's bloodstream with the treated blood are preferably located at the outlet of the adsorber housing. It is preferably a particle filter.
- Reaction solution I 75 mg of CMECDI (2-morpholino-ethanesulfonic acid monohydrate) were at 4 ° C. in 200 ml of 0.1 M MES (N-cyclohexyl-N '- (2-morpholinoethyl) -carbodiimide-methyl-p-toluenesulfate) ) with a pH of 4.75.
- MES N-cyclohexyl-N '- (2-morpholinoethyl) -carbodiimide-methyl-p-toluenesulfate
- 75 mg of polyacrylic acid with a weight-average molecular weight of 800,000 were added, the pH was adjusted to 4.75 and the mixture was stirred at 4 ° C. for 0.5 hour.
- carrier material particles Eupergit C 250L
- 25% NH 3 solution 75 ml of carrier material particles (Eupergit C 250L) in 75 ml of 25% NH 3 solution were stirred overnight in a round bottom flask.
- the carrier material particles were washed three times with water, decanted, suction filtered, washed again with water and dried.
- the carrier material particles were left to swell in 100 ml of n-hexane for 30 minutes, suction filtered on a suction filter for 15 seconds and then immediately added to the reaction solution I described above at 4 ° C., shaken and stirred at 4 ° C. overnight. The particles were then suctioned off, washed with water, 4 M NaCl and again with water and dried in a vacuum desiccator over CaCl 2 .
- reaction solution II The particles treated with reaction solution I were added to this solution, stirred at room temperature for 3 hours and suction filtered.
- the UV absorption at 280 nanometers of the solution was 0.577, corresponding to a concentration of 0.85 g / liter.
- the coupling yield of the reaction solution II was 0.68 g / liter.
- the particles were then washed with 600 ml of PBS, stirred twice in 200 ml of 5 mM ascorbic acid in PBS for one hour at room temperature and suction filtered.
- the particles were stirred for 4 hours in 1 M ethanolamine in PBS at a pH of 8 at room temperature and suction filtered.
- the particles were then stirred twice in 200 ml of 5 mM ascorbic acid in PBS for one hour each at room temperature and suction filtered. Then the particles were washed with the following solutions:
- the particles were autoclaved for 20 minutes at 121 ° C. in 0.154 M NaCl for heat sterilization.
- Adsorbent materials were prepared in the same manner as in Example 1, with the medium used, surface modifications, etc. listed in Table 1. For comparison, adsorbents were produced which had C1q (comparative example 1), PAS (comparative example 2) or OH groups (comparative example 3) as surface modifications on both the inner and the outer surfaces.
- Step A production of a porous carrier material by suspension polymerization
- a porous carrier material is, for example, according to EP 0 495 107 A1 Suspension polymerization produced.
- the carrier material (beads) obtained is filtered off from the mother liquor with an excess pressure of 0.5 bar within 30 s.
- Step B (amination of the outer surface of the carrier material)
- Step C modification of the outer surface of the carrier material with a surface modification Mi
- the filtered carrier material from step B was then added to the solution and incubated for 4 hours at room temperature on a rotary shaker.
- Step D free washing of the pore space of the carrier material
- the carrier material is washed once with 600 ml of a 0.05 M sodium hydroxide solution in 50% isopropanol, four times with 600 ml isopropanol and twice with 600 ml distilled water ,
- Step E (amination of the inner surface of the carrier material)
- Step F (coupling of the amino groups with the surface modification M?)
- FLUKA 0.4% glutardialdehyde solution
- the carrier material was then incubated with 250 ml of a 5 mM ascorbic acid solution (FLUKA) in PP buffer for 4 hours at room temperature on a rotary shaker (in the dark) and with 500 ml each:
- a porous support material was prepared in the same manner as in Example 7, except that Step D was performed before Step C.
- Example 9 Preparation of a porous support material by suspension polymerization in the presence of a water-soluble monomer in the aqueous phase
- FLUKA a 0.4% glutardialdehyde solution
- FLUKA 5mM ascorbic acid solution
- a porous support material was prepared as described in Example 9, except that no acrylic acid was added to the reaction mixture (i.e. to the aqueous phase).
- Example 9 For comparison purposes, a carrier material was produced as in Example 9 and provided with polyacrylic acid on the inner and outer surfaces of the porous carrier material.
Landscapes
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- External Artificial Organs (AREA)
- Polymerisation Methods In General (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/380,193 US7838306B2 (en) | 2000-09-14 | 2001-09-14 | Adsorbent having differently modified surface areas, method for the production thereof and use of the same |
AU2002221596A AU2002221596A1 (en) | 2000-09-14 | 2001-09-14 | Adsorbent having differently modified surface areas, method for the production thereof and use of the same |
JP2002526497A JP2004508188A (ja) | 2000-09-14 | 2001-09-14 | 別々に修飾された表面部分を有する吸着剤、その製造方法およびその使用 |
DE50110410T DE50110410D1 (de) | 2000-09-14 | 2001-09-14 | Adsorbens mit unterschiedlich modifizierten oberflächenbereichen, verfahren zu dessen herstellung und verwendung davon |
EP01984630A EP1326708B1 (de) | 2000-09-14 | 2001-09-14 | Adsorbens mit unterschiedlich modifizierten oberflächenbereichen, verfahren zu dessen herstellung und verwendung davon |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10045434A DE10045434B4 (de) | 2000-09-14 | 2000-09-14 | Adsorbens mit unterschiedlich modifizierten Oberflächenbereichen, Verfahren zu dessen Herstellung und Verwendung davon |
DE10045434.8 | 2000-09-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002022253A2 true WO2002022253A2 (de) | 2002-03-21 |
WO2002022253A3 WO2002022253A3 (de) | 2002-10-10 |
Family
ID=7656160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/010678 WO2002022253A2 (de) | 2000-09-14 | 2001-09-14 | Adsorbens mit unterschiedlich modifizierten oberflächenbereichen, verfahren zu dessen herstellung und verwendung davon |
Country Status (8)
Country | Link |
---|---|
US (1) | US7838306B2 (de) |
EP (1) | EP1326708B1 (de) |
JP (1) | JP2004508188A (de) |
AT (1) | ATE332188T1 (de) |
AU (1) | AU2002221596A1 (de) |
DE (2) | DE10045434B4 (de) |
ES (1) | ES2267838T3 (de) |
WO (1) | WO2002022253A2 (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003024587A2 (de) * | 2001-09-20 | 2003-03-27 | Hemoteq Gmbh | Verfahren zur aufreinigung von vollblut |
US6900157B2 (en) * | 2001-09-10 | 2005-05-31 | Tosoh Corporation | Process for production of partially hydrophilized porous adsorbents |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10325304B3 (de) * | 2003-06-04 | 2005-03-24 | Fresenius Hemocare Adsorber Technology Gmbh | Adsorbens zum Absenken der Konzentration von Fibrinogen und/oder Fibrin in Blut oder Blutplasma, Verfahren zu seiner Herstellung und seine Verwendung |
MX2008007716A (es) | 2005-12-13 | 2008-09-26 | Exthera Ab | Metodo para eliminar extra corporalmente de la sangre un microbio patogeno, una celula inflamatoria o una proteina inflamatoria. |
AU2008265838A1 (en) * | 2007-06-18 | 2008-12-24 | Exthera Medical Llc | Device and method for restoration of the condition of blood |
WO2008155683A1 (en) | 2007-06-18 | 2008-12-24 | Firmenich Sa | Malodor counteracting compositions and method for their use |
KR101876794B1 (ko) | 2009-12-01 | 2018-07-10 | 엑스테라 메디컬 코퍼레이션 | 표면 고정화된 다당류를 이용하여 혈액으로부터 사이토카인을 제거하는 방법 |
AT509192B1 (de) * | 2010-06-24 | 2011-07-15 | Zentrum Fuer Biomedizinische Technologie Der Donau Uni Krems | Sorptionsmittel für endotoxine |
JP5913368B2 (ja) | 2011-01-06 | 2016-04-27 | サイトソーベンツ・コーポレーション | 多孔性ポリマービーズの内部および外部表面の選択的修飾において有用な組成物および方法 |
US8192924B1 (en) | 2011-04-21 | 2012-06-05 | Tcp Reliable, Inc. | Rapid cooling to and maintaining of whole blood at 20 to 24C for processing |
WO2012112724A1 (en) | 2011-02-15 | 2012-08-23 | Exthera Medical, Llc | Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines |
JP6223347B2 (ja) * | 2011-11-01 | 2017-11-01 | パーデュー・リサーチ・ファウンデーションPurdue Research Foundation | 親水性コポリマーコーティングを有するタンパク質クロマトグラフィーマトリックス |
DK2861273T3 (da) | 2012-06-13 | 2017-11-27 | Exthera Medical Corp | Anvendelse af heparin og kulhydrater til behandling af cancer. |
JP6648009B2 (ja) | 2013-06-24 | 2020-02-14 | エクステラ・メディカル・コーポレーション | マンノース被覆基材を含有する血液濾過システム |
MX2016005959A (es) | 2013-11-08 | 2016-10-14 | Exthera Medical Corp | Métodos para diagnosticar enfermedades infecciosas usando medio de adsorción. |
CN106255520B (zh) | 2014-04-24 | 2022-08-12 | 艾克塞拉医疗公司 | 使用高流速从血液除去细菌的方法 |
MX2017003723A (es) | 2014-09-22 | 2017-06-30 | Exthera Medical Corp | Dispositivo de hemoperfusion portatil. |
US11911551B2 (en) | 2016-03-02 | 2024-02-27 | Exthera Medical Corporation | Method for treating drug intoxication |
EP3422943A4 (de) | 2016-03-02 | 2019-10-16 | ExThera Medical Corporation | Verfahren zur behandlung von arzneimittelintoxikation |
JP6862679B2 (ja) * | 2016-05-13 | 2021-04-21 | 昭和電工マテリアルズ株式会社 | 多孔質ポリマ粒子の製造方法 |
US20210370210A1 (en) * | 2018-10-19 | 2021-12-02 | Klaus Gottschall | Filter medium, materials and methods for the removal of contaminants |
EP3969014A4 (de) | 2019-05-16 | 2023-01-25 | ExThera Medical Corporation | Verfahren zur modulation der endothelialen glycocalyxstruktur |
EP4385618A1 (de) * | 2022-12-16 | 2024-06-19 | Chiral Technologies Europe SAS | Verbundmaterial für biotrennungen |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2113226A (en) * | 1982-01-13 | 1983-08-03 | Kureha Chemical Ind Co Ltd | Porous substrate for analyzing hydrophilic substances having low molecular weight |
EP0106769A1 (de) * | 1982-10-15 | 1984-04-25 | Commissariat à l'Energie Atomique | An Oberfläche gepfropftes Trägermaterial, seine Herstellung und diesen Träger enthaltende Adsorbentien für Affinitätschromatographie, sowie deren Verwendung in der Biologie |
US4544485A (en) * | 1984-08-31 | 1985-10-01 | Purdue Research Foundation | Chromatographic method and means |
EP0295809A2 (de) * | 1987-06-17 | 1988-12-21 | Dow Corning Corporation | Zwei-Zonen Packungsmaterial für flüssige Chromatographie und Verfahren zu dessen Herstellung und Verwendung |
FR2653034A1 (fr) * | 1989-10-13 | 1991-04-19 | Centre Nat Rech Scient | Procede de preparation d'un produit particulaire poreux regiospecifique, produits obtenus et application notamment aux separations chromatographiques. |
US5773384A (en) * | 1996-03-23 | 1998-06-30 | White Eagle International Technologies Group, Inc. | Sorbents for removing toxicants from blood or plasma, and method of producing the same |
DE19856387A1 (de) * | 1998-12-07 | 2000-06-08 | Fresenius Ag | Verfahren zur Herstellung eines Adsorbermaterials |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3770631A (en) * | 1971-06-29 | 1973-11-06 | Baxter Laboratories Inc | Clarification of blood serum and plasma |
US4694044A (en) * | 1984-03-09 | 1987-09-15 | Research Development Corp. Of Japan | Adsorbent |
JPS61287444A (ja) * | 1985-06-13 | 1986-12-17 | Toyo Soda Mfg Co Ltd | 二重構造担体 |
JPH0686486B2 (ja) * | 1986-07-10 | 1994-11-02 | 東京有機化学工業株式会社 | 多孔性粒状共重合体の製造方法 |
AU7912887A (en) * | 1986-08-25 | 1988-03-24 | American Biogenetic Sciences, Inc. | Monoclonal antibodies to fibrin |
JPH01123145A (ja) | 1987-11-07 | 1989-05-16 | Japan Spectroscopic Co | カラム用充填剤及びその製造方法 |
DE3914869C1 (de) * | 1989-05-05 | 1990-08-09 | Biotest Pharma Gmbh, 6072 Dreieich, De | |
JP2560856B2 (ja) | 1989-09-21 | 1996-12-04 | 株式会社島津製作所 | カラム充填剤の製造方法 |
JP3164641B2 (ja) * | 1992-04-27 | 2001-05-08 | 積水化学工業株式会社 | 液体クロマトグラフィー用充填剤およびその製造方法 |
DE19545416A1 (de) | 1995-12-06 | 1997-06-12 | Stihl Maschf Andreas | Düse zur Flüssigkeitszufuhr zu einem drehenden Werkzeug |
WO1999016545A1 (de) * | 1997-09-29 | 1999-04-08 | Merck Patent Gmbh | Chemisch-modifizierte, poröse materialien mit elektroneutraler, hydrophiler aussenoberfläche |
JP2000008847A (ja) * | 1998-06-22 | 2000-01-11 | Ebara Corp | 消音装置の連結構造 |
EP1148944B1 (de) * | 1999-01-22 | 2010-04-21 | Dow Global Technologies Inc. | Oberflächenverändertes divinylbenzenharz mit hämokompatibler beschichtung |
-
2000
- 2000-09-14 DE DE10045434A patent/DE10045434B4/de not_active Expired - Fee Related
-
2001
- 2001-09-14 WO PCT/EP2001/010678 patent/WO2002022253A2/de active IP Right Grant
- 2001-09-14 AT AT01984630T patent/ATE332188T1/de not_active IP Right Cessation
- 2001-09-14 ES ES01984630T patent/ES2267838T3/es not_active Expired - Lifetime
- 2001-09-14 AU AU2002221596A patent/AU2002221596A1/en not_active Abandoned
- 2001-09-14 JP JP2002526497A patent/JP2004508188A/ja active Pending
- 2001-09-14 US US10/380,193 patent/US7838306B2/en not_active Expired - Lifetime
- 2001-09-14 EP EP01984630A patent/EP1326708B1/de not_active Expired - Lifetime
- 2001-09-14 DE DE50110410T patent/DE50110410D1/de not_active Expired - Lifetime
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2113226A (en) * | 1982-01-13 | 1983-08-03 | Kureha Chemical Ind Co Ltd | Porous substrate for analyzing hydrophilic substances having low molecular weight |
EP0106769A1 (de) * | 1982-10-15 | 1984-04-25 | Commissariat à l'Energie Atomique | An Oberfläche gepfropftes Trägermaterial, seine Herstellung und diesen Träger enthaltende Adsorbentien für Affinitätschromatographie, sowie deren Verwendung in der Biologie |
US4544485A (en) * | 1984-08-31 | 1985-10-01 | Purdue Research Foundation | Chromatographic method and means |
EP0295809A2 (de) * | 1987-06-17 | 1988-12-21 | Dow Corning Corporation | Zwei-Zonen Packungsmaterial für flüssige Chromatographie und Verfahren zu dessen Herstellung und Verwendung |
FR2653034A1 (fr) * | 1989-10-13 | 1991-04-19 | Centre Nat Rech Scient | Procede de preparation d'un produit particulaire poreux regiospecifique, produits obtenus et application notamment aux separations chromatographiques. |
US5773384A (en) * | 1996-03-23 | 1998-06-30 | White Eagle International Technologies Group, Inc. | Sorbents for removing toxicants from blood or plasma, and method of producing the same |
DE19856387A1 (de) * | 1998-12-07 | 2000-06-08 | Fresenius Ag | Verfahren zur Herstellung eines Adsorbermaterials |
Non-Patent Citations (2)
Title |
---|
DATABASE WPI Section Ch, Week 198809 Derwent Publications Ltd., London, GB; Class A13, AN 1988-061318 XP002208708 & JP 63 017906 A (TOKYO ORGANIC CHEM IND CO LTD), 25. Januar 1988 (1988-01-25) * |
DATABASE WPI Section Ch, Week 199350 Derwent Publications Ltd., London, GB; Class A89, AN 1993-400805 XP002208709 & JP 05 302917 A (SEKISUI CHEM IND CO LTD) , 16. November 1993 (1993-11-16) * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6900157B2 (en) * | 2001-09-10 | 2005-05-31 | Tosoh Corporation | Process for production of partially hydrophilized porous adsorbents |
WO2003024587A2 (de) * | 2001-09-20 | 2003-03-27 | Hemoteq Gmbh | Verfahren zur aufreinigung von vollblut |
WO2003024587A3 (de) * | 2001-09-20 | 2003-07-10 | Hemoteq Gmbh | Verfahren zur aufreinigung von vollblut |
Also Published As
Publication number | Publication date |
---|---|
AU2002221596A1 (en) | 2002-03-26 |
US20040202783A1 (en) | 2004-10-14 |
DE10045434A1 (de) | 2002-04-04 |
EP1326708B1 (de) | 2006-07-05 |
ATE332188T1 (de) | 2006-07-15 |
JP2004508188A (ja) | 2004-03-18 |
WO2002022253A3 (de) | 2002-10-10 |
DE50110410D1 (de) | 2006-08-17 |
US7838306B2 (en) | 2010-11-23 |
DE10045434B4 (de) | 2005-07-14 |
ES2267838T3 (es) | 2007-03-16 |
EP1326708A2 (de) | 2003-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1326708B1 (de) | Adsorbens mit unterschiedlich modifizierten oberflächenbereichen, verfahren zu dessen herstellung und verwendung davon | |
DE69319471T2 (de) | Filtermedium mit begrenzter negativer Oberflächenladung für die Behandlung von Blutmaterial | |
DE69327891T2 (de) | Material zur Entfernung von pathogener Substanz und mit diesem Material hergestellter Blutfilter | |
EP1578526B1 (de) | Adsorbermaterial für blut-, blutplasma- und albuminreinigungsverfahren | |
DE2431920A1 (de) | Ueberzogenes absorbensmaterial | |
DE3412616A1 (de) | Adsorbens fuer autoantikoerper- und immunkomplexe, dieses enthaltende adsorptionsvorrichtung und dieses enthaltender blutreinigungsapparat | |
DE3115608A1 (de) | Saeule fuer die adsorption von blutproteinen | |
DE69834651T2 (de) | Filtermaterial zur entfernung von weissen blutkörperchen | |
WO2011160149A1 (de) | Neuartiges sorptionsmittel für endotoxine | |
EP3484612A1 (de) | Chromatographiemedium mit gebundenen mikroglobuli und verfahren zu dessen herstellung | |
EP0424698B1 (de) | Zur Eliminierung von Biomakromolekülen insbesondere LDL und Endotoxinen, aus Vollblut in extrakorporalem Kreislauf geeignetes Adsorbens | |
DE69837993T2 (de) | Adsorbentien für toxisches schocksyndrom toxin-1, verfahren zur beseitigung des toxins durch adsorbtion | |
DE69621597T2 (de) | Adsorbens für tumornekrosefaktor alpha, methode zur entfernung durch adsorption und adsorptionsvorrichtung unter verwendung des adsorbens | |
DE69530761T2 (de) | Methode und poröser träger zur entfernung von verunreinigungen | |
DE69734749T2 (de) | Vorrichtung mit adsorbens zum adsorptiven entfernen von krankheitsbedingten faktoren in körperflüssigkeiten | |
DE10147463B4 (de) | Verfahren zur Herstellung eines Absorbers, Absorber und dessen Verwendung | |
DE3926539C2 (de) | ||
Wang et al. | Plant protein modified natural cellulose with multiple adsorption effects used for bilirubin removal | |
EP1132128B1 (de) | Verwendung des Adsorbens zur Herstellung eines Adsorbers zum Absenken der Konzentration von Fibrinogen und/oder Fibrin | |
DE10011482B4 (de) | Verfahren zum Herstellen eines Adsorbens zum Absenken der Konzentration von Fibrinogen und/oder Fibrin, Adsorbens und Verwendung des Adsorbens zur Herstellung eines Adsorbers | |
EP1679117A2 (de) | Adsorptionssystem zur Entfernung von Viren und viralen Bestandteilen aus Flüssigkeiten, insbesondere aus Blut und Blutplasma | |
EP3116644B1 (de) | Adsorbergranulat zur entfernung urämischer toxine | |
DE10325304B3 (de) | Adsorbens zum Absenken der Konzentration von Fibrinogen und/oder Fibrin in Blut oder Blutplasma, Verfahren zu seiner Herstellung und seine Verwendung | |
DD265470A1 (de) | Spezifisches adsorbens zur bindung von anti-dna-autoantikoerpern |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001984630 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002526497 Country of ref document: JP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001984630 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10380193 Country of ref document: US |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001984630 Country of ref document: EP |